Unable to load price data. Sorry.

¯\_(ツ)_/¯

Molecular Templates Inc (NASDAQ:MTEM)

CAPS Rating: 1 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ:MTEM will perform against the market?

Add Stock to CAPS Watchlist

All Players

103 Outperform
21 Underperform
 

All-Star Players

16 Outperform
6 Underperform
 

Wall Street

9 Outperform
1 Underperform
 

Top NASDAQ:MTEM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TrackUltraLong (< 20)
Submitted June 06, 2012

http://www.fool.com/investing/high-growth/2012/06/05/capscall-of-the-week-threshold-pharmaceuticals.aspx

TerryHogan (99.97)
Submitted December 14, 2018

Another biotech waiting for a hit. These are like lottery tickets to invest in. Which is to say the odds are against you and your expected payout is zero, and you're foolish for putting a lot of money into them. Having said all of that, every once in… More

NASDAQ:MTEM VS S&P 500 (SPY)

Fools bullish on NASDAQ:MTEM are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about MTEM.

Recs

1
Member Avatar TerryHogan (99.97) Submitted: 12/14/2018 2:04:35 AM : Underperform Start Price: $4.73 NASDAQ:MTEM Score: -4.68

Another biotech waiting for a hit. These are like lottery tickets to invest in. Which is to say the odds are against you and your expected payout is zero, and you're foolish for putting a lot of money into them. Having said all of that, every once in a while one of them pays off and you win big. That's why shorting them can be dangerous in real life, but here you're better off playing the odds. Red Thumb. See also: share issuance to pay the bills.

Recs

0
Member Avatar smartgainer (< 20) Submitted: 9/27/2016 8:09:25 AM : Outperform Start Price: $13.09 NASDAQ:MTEM Score: -100.77

Clinical trials results for promising cancer drug coming soon.

Recs

0
Member Avatar Ted2400 (53.11) Submitted: 9/2/2016 4:52:37 PM : Outperform Start Price: $13.20 NASDAQ:MTEM Score: -101.90

Market cap is only $80 million. Approval of their lead compound would push this to a billion plus company.

Leaderboard

Find the members with the highest scoring picks in MTEM.

Score Leader

efarev

efarev (98.11) Score: +343.18

The Score Leader is the player with the highest score across all their picks in MTEM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
disquisitor 57.71 5/30/2012 Underperform 3M $79.00 -92.65% +135.92% +228.56 0 Comment
hlacheen 99.00 10/5/2006 Underperform 5Y $30.03 -80.65% +144.19% +224.84 0 Comment
jsGreenmachine < 20 2/22/2012 Underperform 5Y $59.07 -90.16% +127.87% +218.03 0 Comment
schoolhouserd < 20 1/3/2007 Underperform 1Y $41.80 -86.10% +131.83% +217.93 0 Comment
bonoway < 20 1/22/2007 Underperform 3M $39.49 -85.29% +130.51% +215.79 0 Comment
mainakn 63.15 2/16/2011 Underperform 1Y $34.43 -83.13% +132.11% +215.23 0 Comment
woodsst 74.51 12/22/2006 Underperform 5Y $32.78 -82.28% +132.82% +215.10 0 Comment
3acrerock 69.62 1/3/2007 Underperform 1Y $37.51 -84.51% +130.48% +214.99 0 Comment
Hotpicks101 28.36 2/9/2012 Underperform 3W $35.75 -83.75% +129.69% +213.44 0 Comment
jdill23 < 20 4/3/2012 Underperform 3M $80.85 -92.81% +120.39% +213.20 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MTEM.